Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN104388490A reveals high-yield biocatalytic route. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN118666746A enables solid-state purification of Mivacurium intermediate, ensuring >99.5% purity and scalable manufacturing for reliable supply chains.
Novel enzymatic resolution method for chiral spiro compounds. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN110041369A details a high-purity synthesis route for Tenofovir Disoproxil Fumarate, offering significant supply chain stability and cost reduction benefits for API manufacturing.
Novel aqueous-based method for Montelukast improves yield and safety. Ideal for reliable pharmaceutical intermediate supplier partnerships.
Patent CN107033125B reveals a streamlined Alectinib synthesis route. Discover how this method reduces purification steps and enhances supply chain reliability for pharmaceutical intermediates.
Patent CN102924473B reveals a high-yield synthesis route for 2-chloro-7-iodothieno[3,2-D]pyrimidine, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN111909048B reveals a green one-pot method for Atorvastatin intermediates. Discover cost reduction in API manufacturing and reliable supply chain solutions.
Novel enzymatic coupling method for (S)-phenylethylene glycol production. Reduces coenzyme costs and improves supply chain reliability for pharmaceutical intermediates globally.
Novel high-temperature water hydrolysis method enhances yield and reduces waste in gabapentin manufacturing, offering cost-effective supply chain solutions.
Patent CN102391254A reveals a cost-effective Candesartan synthesis using ethoxycarbonyl protection, eliminating deprotection steps and reducing manufacturing costs for API intermediates.
Novel solvent system method improves Etravirine yield and purity. Reduces steps for reliable pharmaceutical intermediate supplier cost efficiency.
Patent CN109928963B details a novel synthesis for antibacterial urolithin B derivatives, offering improved solubility and scalable manufacturing for pharmaceutical supply chains.
Patent CN109942633B reveals a high-yield route for TAF intermediates using DMA solvent, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN102050781B details a high-purity industrial preparation method for hydroxychloroquine sulfate, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Discover a novel palladium-free synthesis route for Roxadustat intermediates offering significant cost reduction and simplified purification for reliable pharmaceutical supply chains.
Patent CN102718810B reveals advanced after-treatment for benzylation products. Achieve higher purity and yield for reliable pharmaceutical intermediates supply chain.
Patent CN112961153B details a safe, high-yield route for moxifloxacin impurities, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN105949146A reveals a novel esterification route for anti-tuberculosis hybrids, offering high purity and scalable manufacturing for global supply chains.
Patent CN110684068A reveals a high-yield hydrolysis method for prednisone intermediates, offering significant cost reduction and scalable manufacturing for pharmaceutical supply chains.